Calcium channel blockade in dialysis patients with left ventricular hypertrophy and well-preserved systolic function

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Chronic hemodialysis patients often experience refractory pulmonary congestion.
• Dialysis can be associated with intradialytic hypotension.
• Left ventricular hypertrophy (LVH) is a common comorbidity.

Purpose of the Study:

• To investigate the characteristics of LVH in hemodialysis patients with refractory congestive heart failure.
• To evaluate the efficacy of verapamil in managing symptoms and intradialytic complications in this patient subset.

Main Methods:

• Echocardiography was used to assess left ventricular structure and function.
• Four patients with chronic hemodialysis, refractory pulmonary congestion, and dialysis-related hypotension were treated with verapamil (40 mg t.i.d.).
• Clinical outcomes including symptomatic improvement, blood pressure, and need for interventions were monitored.

Main Results:

• Echocardiography confirmed LVH with preserved systolic function in all patients.
• Verapamil treatment led to symptomatic improvement.
• An increase in nadir intradialysis blood pressure and a reduction in hypertensive episodes and saline administration were observed.

Conclusions:

• A subset of chronic hemodialysis patients with congestive heart failure and hypotension exhibit hypertrophic cardiomyopathy with preserved systolic function.
• Verapamil may be a beneficial treatment option for these patients, potentially superior to conventional therapies like digoxin and nitrates.